6533b82dfe1ef96bd1290910

RESEARCH PRODUCT

Non-invasive visual tools for diagnosis of oral cancer and dysplasia: a systematic review

Marco MeletiMaddalena ManfrediIlaria GiovannacciPaolo Vescovi

subject

Pathologymedicine.medical_specialtyMEDLINEOdontologíaReviewSensitivity and Specificity03 medical and health sciences0302 clinical medicinePositive predicative valueCarcinomamedicineHumansTolonium ChlorideGeneral DentistryOral DysplasiaOral Medicine and PathologyHyperplasiabusiness.industryCancer030206 dentistryGold standard (test)medicine.disease:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludClinical trialstomatognathic diseasesOtorhinolaryngologyDysplasia030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASCarcinoma Squamous CellSurgeryMouth NeoplasmsRadiologybusiness

description

Background: Gold standard for the diagnosis of oral dysplasia (OD) oral squamous cell carcinoma (OSCC) and malignant lesions is the histological examination. Several adjunctive diagnostic techniques have been proposed in order to increase the sensitivity (SE) and specificity (SP) of conventional oral examination and to improve the diagnostic first level accuracy. The aim of this study is to perform a systematic review on non-invasive tools for diagnosis of OD and early OSCC. Material and Methods: Medline, Scopus, Web of Knowledge databases were searched, using as entry terms “oral dysplasia AND diagnosis” / ”oral cancer AND diagnosis”. Data extracted from each study included number of lesions evaluated, histopathological diagnosis, SE, SP, positive and negative predictive values (PPV and NPV), diagnostic accuracy (DA) and the main conclusions. Results: After title and abstract scanning of 11.080 records, we selected 35 articles for full text evaluation. Most evaluated tools were autofluorescence (AF), chemiluminescence (CL), toluidine blu (TL) and chemiluminescence associated with toluidine blue (CLTB). Conclusions: There is a great inhomogeneity of the reported values and there is no significant evidence of superiority of one tool over the other. Further clinical trials with a higher level of evidence are necessary in order to assess the real usefulness visual diagnostic tools.

http://hdl.handle.net/10550/54773